Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Lower respiratory tract Stories

2013-11-13 10:40:49

A study published this week in PLOS Medicine reveals profound systemic dysregulation of the immune response induced by RSV infection in young children and suggest that molecular markers might be able to predict disease severity. RSV is responsible for a substantial fraction of serious respiratory infections and deaths among young children worldwide and a top candidate for vaccine development. A team of researchers led by Asuncion Mejias and Octavio Ramilo, both from The Research...

2013-04-19 16:59:24

Study offers understanding of asthma development The most common cause of lower respiratory tract infections in infants and young children, respiratory syncytial virus (RSV), can be transferred during pregnancy to an unborn baby, according to Cleveland Clinic Children's Hospital research published online this week in the journal PLOS ONE. In animal models, the study shows that RSV is able to spread across the placenta from the respiratory tract of the mother to the fetus, and is...

2012-01-10 15:35:37

A new study supports previous findings that children delivered by caesarean section have an increased risk of developing asthma. The study from the Norwegian Mother and Child Cohort Study (MoBa) suggests that children delivered by caesarean section have an increased risk of asthma at the age of three. This was particularly seen among children without a hereditary tendency to asthma and allergies. Data from more than 37 000 participants in the MoBa study were used to study the...

2012-01-03 11:56:00

EXTON, Pa., Jan. 3, 2012 /PRNewswire/ -- Pharmaxis, Inc. today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a product-specific billing code, or J-code, for ARIDOL® (mannitol inhalation powder) Bronchial Challenge Test Kit. The unique, product-specific billing code, J7665 (mannitol, administered through an inhaler, 5 mg), became effective on January 1, 2012. (Photo: http://photos.prnewswire.com/prnh/20111107/NY00591 ) ARIDOL, the only dry powder...

2011-12-06 12:40:25

Research findings challenges medical textbooks A ground-breaking international study into the ways lungs grow and develop has challenged existing medical understanding that our lungs are completely formed by the age of three. The researchers, led by a team at the University of Leicester, put forward a theory for the first time based on research evidence that new air sacs, called alveoli, are constantly being formed. This contradicts information in most medical textbooks that explain...

2011-02-23 15:20:00

EXTON, Pa., Feb. 23, 2011 /PRNewswire/ -- Pharmaxis, a global specialty pharmaceutical company focused on therapeutic products for chronic respiratory and immune disorders, announced today the commercial launch of ARIDOL® (mannitol inhalation powder) Bronchial Challenge Test Kit, the first new bronchial challenge test in more than two decades and the company's first product launch in the U.S. ARIDOL is used to assess bronchial hyperresponsiveness in patients six years...

2010-10-06 12:13:00

EXTON, Pa., Oct. 6 /PRNewswire/ -- Pharmaxis, a global specialty pharmaceutical company focused on therapeutic products for chronic respiratory and immune disorders, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market ARIDOL(TM) (mannitol inhalation powder) Bronchial Challenge Test Kit, the first new bronchial challenge test in more than two decades. ARIDOL is used for the assessment of bronchial hyperresponsiveness in patients six...

2010-01-29 13:00:00

GAITHERSBURG, Md., Jan. 29 /PRNewswire/ -- MedImmune today announced that clinical results of its pivotal multinational, randomized, double-masked trial for motavizumab have been published in the current issue of the peer-reviewed publication, Pediatrics: Official Journal of the American Academy of Pediatrics. Motavizumab is an investigational monoclonal antibody (MAb) being evaluated by the FDA for its potential to prevent serious disease caused by respiratory syncytial virus (RSV)...

2009-05-06 08:16:31

Even mildly premature infants (gestational ages of 33 weeks through 36 weeks) have an increased risk of medically attended respiratory syncytial virus infection, which is the leading cause of lower respiratory tract infection in infants and young children and can lead to pneumonia in babies, according to a Kaiser Permanente Division of Research study. The RSV infection risk is higher among infants exposed to supplemental oxygen or assisted ventilation during the neonatal period, said the...

2008-07-10 18:00:12

WASHINGON, July 10 /PRNewswire-USNewswire/ -- A new report issued today by the Centers for Disease Control (CDC) exemplifies the need for nonsmoking Americans to be better protected against exposure to secondhand smoke. The report finds that 46 percent of Americans show biologic exposure to the deadly toxins found in cigarettes. Even more startling are the millions of children this statistic includes. In fact, recent studies indicate that 21 million or 35 percent of children are exposed to...